Category: Isotopes

Move from HEU to LEU Nearing Completion in the United States

Technetium (Tc-99m), the decay product of molybdenum-99 (Mo-99), is an essential component in cardiac nuclear imaging. In the past, the primary source for this radioisotope was highly enriched uranium (HEU), but market dynamics and legislative action have changed that. The last five years have seen a sustained move to low-enriched

Read More »

Search

Categories
A Catalyst MedTech Company

©2025 Catalyst MedTech. All rights reserved.